Eli Lilly & Company recalls Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indian
Recalled August 18, 2021 · FDA recall D-0720-2021 · Eli Lilly &
Hazard
cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product. · FDA Class II
Units
36,540 vials
Sold at
OH, MS, IN
Description
cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
Product
Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01
Manufacturer(s)
Eli Lilly & Company
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →